|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-6-24
|
|
pubmed:abstractText |
The structure of a 36-amino-acid-long N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17 and Cys-36-->Ser mutated was determined from nuclear magnetic resonance data in aqueous solution containing 30% trifluoroethanol. The peptide assumes a conformation characterized by two alpha-helices connected by an irregular strand, which comprises the amino acids from Arg-13 to Pro-21. The proline is in a trans conformation. The two phosphate groups on Ser-16 and Thr-17 are shown to interact preferably with the side chains of Arg-14 and Arg-13, respectively. The helix comprising amino acids 22 to 35 is well determined (the rmsd for the backbone atoms, calculated for a family of 24 nuclear magnetic resonance structures is 0.69 +/- 0.28 A). The structures of phosphorylated and unphosphorylated phospholamban are compared, and the effect of the two phosphate groups on the relative spatial position of the two helices is examined. The packing parameters Omega (interhelical angle) and d (minimal interhelical distance) are calculated: in the case of the phosphorylated phospholamban, Omega = 100 +/- 35 degrees and d = 7.9 +/- 4.6 A, whereas for the unphosphorylated peptide the values are Omega = 80 +/- 20 degrees and d = 7.0 +/- 4.0 A. We conclude that 1) the phosphorylation does not affect the structure of the C terminus between residues 21 and 36 and 2) the phosphorylated phospholamban has more loose helical packing than the nonphosphorylated.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-10024311,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-10096878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-10491139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-10603937,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-1490109,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-1737021,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-2545189,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-2829866,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-4066656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-7265198,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-7529751,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-7779806,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8062415,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8428955,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8567978,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8617290,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8621468,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-8645206,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-9062126,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-9468536,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-9876124,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12080135-9887981
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0006-3495
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
484-90
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:12080135-Arginine,
pubmed-meshheading:12080135-Calcium-Binding Proteins,
pubmed-meshheading:12080135-Humans,
pubmed-meshheading:12080135-Magnetic Resonance Spectroscopy,
pubmed-meshheading:12080135-Models, Molecular,
pubmed-meshheading:12080135-Phosphorylation,
pubmed-meshheading:12080135-Proline,
pubmed-meshheading:12080135-Protein Conformation,
pubmed-meshheading:12080135-Protein Structure, Tertiary,
pubmed-meshheading:12080135-Serine,
pubmed-meshheading:12080135-Threonine
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.
|
|
pubmed:affiliation |
Orion Pharma, Cardiovascular Research, FIN-02101 Espoo, Finland. piero.pollesello@orionpharma.com
|
|
pubmed:publicationType |
Journal Article
|
